NO178498C - Analogifremgangsmåte ved fremstilling av terapeutisk aktive karbapenemderivater - Google Patents

Analogifremgangsmåte ved fremstilling av terapeutisk aktive karbapenemderivater

Info

Publication number
NO178498C
NO178498C NO910723A NO910723A NO178498C NO 178498 C NO178498 C NO 178498C NO 910723 A NO910723 A NO 910723A NO 910723 A NO910723 A NO 910723A NO 178498 C NO178498 C NO 178498C
Authority
NO
Norway
Prior art keywords
therapeutically active
analogous method
carbapenem derivatives
preparing therapeutically
active carbapenem
Prior art date
Application number
NO910723A
Other languages
English (en)
Norwegian (no)
Other versions
NO178498B (no
NO910723D0 (no
NO910723L (no
Inventor
Isao Kawamoto
Masao Miyauchi
Eiji Nakayama
Rokuro Endo
Satoshi Ohya
Yukio Utsui
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO910723D0 publication Critical patent/NO910723D0/no
Publication of NO910723L publication Critical patent/NO910723L/no
Publication of NO178498B publication Critical patent/NO178498B/no
Publication of NO178498C publication Critical patent/NO178498C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO910723A 1990-02-23 1991-02-22 Analogifremgangsmåte ved fremstilling av terapeutisk aktive karbapenemderivater NO178498C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4279690 1990-02-23
JP21228390 1990-08-10

Publications (4)

Publication Number Publication Date
NO910723D0 NO910723D0 (no) 1991-02-22
NO910723L NO910723L (no) 1991-08-26
NO178498B NO178498B (no) 1996-01-02
NO178498C true NO178498C (no) 1996-04-10

Family

ID=26382533

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910723A NO178498C (no) 1990-02-23 1991-02-22 Analogifremgangsmåte ved fremstilling av terapeutisk aktive karbapenemderivater

Country Status (13)

Country Link
US (2) US5310735A (fr)
EP (1) EP0443883A1 (fr)
KR (1) KR910021402A (fr)
AU (1) AU646012B2 (fr)
CA (1) CA2036941A1 (fr)
CZ (1) CZ289263B6 (fr)
FI (1) FI96863C (fr)
HU (1) HUT58100A (fr)
IE (1) IE910606A1 (fr)
NO (1) NO178498C (fr)
NZ (1) NZ237191A (fr)
PT (1) PT96872A (fr)
RU (1) RU2059639C1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU631671B2 (en) * 1989-08-04 1992-12-03 Banyu Pharmaceutical Co., Ltd. 2-(2-vinylpyrrolidinylthio)carbapenem derivatives
NZ237191A (en) * 1990-02-23 1992-12-23 Sankyo Co 2-((substituted amide) substituted heterocyclylthio) carbpen-2-em derivatives and pharmaceutical compositions
GB9107363D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
US5554606A (en) * 1990-03-12 1996-09-10 Zeneca Limited Antibiotic compounds
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
AU651887B2 (en) * 1991-06-04 1994-08-04 Sankyo Company Limited 1-methylcarbapenem derivatives, their preparation and their use as antibiotics
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
HU218676B (hu) * 1992-03-11 2000-10-28 Sankyo Co. Ltd. Antimikrobiális karbapenemszármazékok, ilyen vegyületeket tartalmazó gyógyászati készítmények és eljárás ezek előállítására
GB9304156D0 (en) * 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
EP0581501B1 (fr) * 1992-07-21 1998-09-09 Zeneca Limited Dérivés de carbapénème antibiotiques
CA2099817A1 (fr) * 1992-07-21 1994-01-22 Frederic H. Jung Composes antibiotiques
EP0581502B1 (fr) * 1992-07-21 1998-10-21 Zeneca Limited Dérivés de carbapénème antibiotiques
CA2099818A1 (fr) * 1992-07-21 1994-01-22 Frederic H. Jung Composes antibiotiques
CA2099811A1 (fr) * 1992-07-21 1994-01-22 Frederic H. Jung Composes antibiotiques
CA2106141A1 (fr) * 1992-09-28 1994-03-29 Michael J. Betts Composes antibiotiques
EP0590885B1 (fr) * 1992-09-28 2000-03-15 Zeneca Limited Dérivés de carbapénème antibiotiques
CA2106330A1 (fr) * 1992-10-07 1994-04-08 Patrice J. Siret Composes antibiotiques
AU4912393A (en) * 1993-06-15 1994-12-22 Dong Kook Pharmaceutical Co., Ltd. 1-beta-methyl-2-thiolic carbapenem derivatives
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
NZ332453A (en) * 1996-04-26 2000-09-29 Sankyo Co (1R,5S,6S)-6-[(1R)-1-hydroxyethyl]-1-methyl-2-[(2S,4S)-2-[(3R)-3-methylaminomethylpyrrolidin-1-ylcarbonyl]pyrrolidin-4-ylthio]-1-carbapen-2-em-3-carboxylic acid for the prevention or treatment of bacterial infections
JP2001500118A (ja) 1996-08-17 2001-01-09 ゼネカ・リミテッド ファルネシルタンパク質トランスフェラーゼ阻害剤としての３―メルカプトピロリジン
CA2303446C (fr) 1997-09-13 2004-10-26 Korea Institute Of Science And Technology Derives de carbapenem et leur procede de preparation
YU66700A (sh) * 1998-05-01 2003-01-31 Kyoto Pharmaceutical Industries Ltd. Derivati karbapenema, njihovo korišćenje i intermedijarna jedinjenja istih
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
US7932381B2 (en) * 2005-02-15 2011-04-26 Shionogi & Co., Ltd. Process for producing carbapenem derivative and intermediate crystal therefor
EP2177522B1 (fr) 2007-06-28 2013-09-04 XuanZhu Pharma Co., Ltd. Nouveaux dérivés de carbapénème

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
US4194047A (en) * 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
NL8000469A (nl) * 1980-01-25 1981-01-30 Akzo Nv Zonnecollector met een warmtewisselaar.
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
AR241016A1 (es) * 1983-03-08 1991-04-30 Bristol Myeres Squibb Company "derivados de aminotiol cuaternario, procedimiento para prepararlos y procedimiento para preparar compuestos de carbapenem a partir de dichos derivados".
CA1283906C (fr) * 1983-05-09 1991-05-07 Makoto Sunagawa COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION
DK189686A (da) * 1985-04-27 1986-10-28 Sankyo Co Carbapenemforbindelser og fremgangsmaade til fremstilling deraf samt middel indeholdende forbindelserne
EP0243686B1 (fr) * 1986-03-27 1992-07-15 Sumitomo Pharmaceuticals Company, Limited Dérivés de bêta-lactame et leur préparation
NZ219892A (en) * 1986-04-15 1991-02-26 Merck & Co Inc N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof
US4925838A (en) * 1988-03-18 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
US5227376A (en) * 1990-02-14 1993-07-13 Sumitomo Pharmaceuticals Co., Ltd. β-lactam compounds and their production
CA2036163C (fr) * 1990-02-14 2001-06-19 Makoto Sunagawa Nouveaux composes de beta-lactame et leur production
NZ237191A (en) * 1990-02-23 1992-12-23 Sankyo Co 2-((substituted amide) substituted heterocyclylthio) carbpen-2-em derivatives and pharmaceutical compositions
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use

Also Published As

Publication number Publication date
CZ289263B6 (cs) 2001-12-12
NZ237191A (en) 1992-12-23
AU646012B2 (en) 1994-02-03
PT96872A (pt) 1991-10-31
IE910606A1 (en) 1991-08-28
NO178498B (no) 1996-01-02
NO910723D0 (no) 1991-02-22
KR910021402A (ko) 1991-12-20
FI910860A7 (fi) 1991-08-24
EP0443883A1 (fr) 1991-08-28
NO910723L (no) 1991-08-26
CA2036941A1 (fr) 1991-08-24
FI910860A0 (fi) 1991-02-22
CS9100483A2 (en) 1991-10-15
FI96863B (fi) 1996-05-31
US5420119A (en) 1995-05-30
HUT58100A (en) 1992-01-28
RU2059639C1 (ru) 1996-05-10
FI96863C (fi) 1996-09-10
HU910620D0 (en) 1991-09-30
AU7132291A (en) 1991-08-29
US5310735A (en) 1994-05-10

Similar Documents

Publication Publication Date Title
NO178498C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive karbapenemderivater
NO176796C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater
NO179283C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
NO174547C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive didehydro-vitamin-D3-derivater
NO174101C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
NO172540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrrolderivater
NO180586C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO178543C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater
NO180749C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolsubstituerte derivater
NO175478C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive diazepin-derivater
FI923527L (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-piperidino-4-hydroksikromaanijohdannaisten valmistamiseksi
NO180084C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
FI930723A0 (fi) Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO175429C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 16-dehydro-vitamin-D3-derivater
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
NO178967C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
FI924642L (fi) Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi
NO176100C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
NO178624C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-substituerte alkyl-3-karboksy-karbapenemer
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser